Biopharmaceutical Competitive Intelligence 4th April 2016, London, United Kingdom
Competitive Intelligence (“CI”) is a strategic and tactical methodology to derive deep, accurate and actionable insight into the overarching competitive landscape. In the biopharmaceutical sector, CI is leveraged as a means of understanding in-market, as well as developmental pipeline and emerging players, assets and threats. CI is an extremely powerful resource when appropriately undertaken and actionably implemented.
This workshop will review competitive intelligence in the biopharmaceutical sector, as well as delineate how it can be effectively implemented into the standard day-to-day practices of biopharmaceutical companies, globally. We will review and discuss broad-based competitive assessments, as well as focus on key “hot spots” in biopharmaceutical CI such as biosimilars and generics and manufacturing and supply chain logistics intelligence.
